{"slug":"deepmind-alphagenome-2-0456dde7","url":"https://silinex.xyz/wire/deepmind-alphagenome-2-0456dde7","json_url":"https://silinex.xyz/wire/deepmind-alphagenome-2-0456dde7.json","md_url":"https://silinex.xyz/wire/deepmind-alphagenome-2-0456dde7.md","headline":"Google DeepMind releases AlphaGenome 2 gene sequence model: nearly doubles the ability to identify pathogenic variants","headline_zh":"谷歌 DeepMind 发布 AlphaGenome 2 基因序列模型：识别致病变异能力提升近一倍","title":"Google DeepMind releases AlphaGenome 2 gene sequence model: nearly doubles the ability to identify pathogenic variants","summary":"Compiled from publicly available reports such as IT Home: Google DeepMind has released a new generation DNA sequence model, AlphaGenome 2, which can predict the effects of DNA sequences and their variations on specifi…","summary_zh":"综合 IT之家 等公开报道整理：谷歌 DeepMind 发布新一代 DNA 序列模型 AlphaGenome 2 ，可预测 DNA 序列及其变异对特定人体细胞类型的影响，为科研人员挖掘疾病的细胞驱动因素提供全新工具。","date_published":"2026-11-11T15:19:51.000+00:00","date_modified":"2026-11-11T16:21:26.422+00:00","author":{"type":"Organization","name":"IT之家","url":"https://www.ithome.com/1/025/822.htm"},"publisher":{"name":"Silicon Nexus","url":"https://silinex.xyz/"},"category":"ai","language":"zh","source_url":"https://www.ithome.com/1/025/822.htm","source_name":"IT之家","key_facts":["IT Home, November 11 – Google DeepMind has released a new generation DNA sequence model, AlphaGenome 2, which can predict the effects of DNA sequences and their variations on specific human cell types, providing researchers with a new tool to explore the cellular drivers of diseases.","Every cell in the human body carries the same DNA blueprint, but different cell types perform specific functions by switching different genes on and off.","The Human Cell Atlas project worldwide has mapped the gene expression of millions of cells, but predicting how subtle DNA variations affect cellular gene expression remains an unsolved challenge.","Previously, Google had launched the first-generation AlphaGenome, which can predict the impact of DNA variants on the molecular activity of broad tissues, and released the AlphaGenome Atlas, covering predictions for all 9 billion single-letter variants in the human genome, aiding research on rare diseases, complex traits, and basic biology."],"key_facts_zh":["IT之家 11 月 11 日消息，谷歌 DeepMind 发布新一代 DNA 序列模型 AlphaGenome 2 ，可预测 DNA 序列及其变异对特定人体细胞类型的影响，为科研人员挖掘疾病的细胞驱动因素提供全新工具。","人体每个细胞携带相同的 DNA 蓝图，但不同细胞类型会通过开关不同基因完成特定功能。","全球的人类细胞图谱项目已对数百万细胞的基因表达进行绘制，但预测细微 DNA 变异如何影响细胞基因表达，仍是尚未解决的难题。","此前谷歌已推出初代 AlphaGenome ，可预测 DNA 变异对宽泛组织的分子活性影响，并推出了覆盖人类基因组全部 90 亿种单字母变异预测的 AlphaGenome Atlas ，助力罕见病、复杂性状与基础生物学研究。"],"body_md":"## Wire brief\n\nCompiled from publicly available reports such as IT Home: Google DeepMind has released a new generation DNA sequence model, AlphaGenome 2, which can predict the effects of DNA sequences and their variations on specific human cell types, providing researchers with a new tool to explore the cellular drivers of diseases.\n\nIn terms of the context of the events, every human cell carries the same DNA blueprint, but different cell types perform specific functions by switching different genes on and off. The global Human Cell Atlas project has mapped the gene expression of millions of cells, yet predicting how subtle DNA variations affect cellular gene expression remains an unsolved challenge. Previously, Google launched the first-generation AlphaGenome, which can predict the effects of DNA variations on molecular activity in broad tissues, and introduced the AlphaGenome Atlas, which covers predictions for all 9 billion single-letter variations in the human genome, aiding research in rare diseases, complex traits, and basic biology.\n\nPublic information also mentions: AlphaGenome 2 reduces from the average level of broad tissues to individual cell types and states, and reconstructs the model architecture. Its variant prediction performance achieves a stepwise improvement, capable of capturing variant effects in disease-relevant cells missed by broad tissue models, and can also make predictions for cell and disease states that the model has not seen. According to IT Home, compared with the previously optimal model, AlphaGenome 2 can identify nearly twice as many variants that can alter gene expression within cells. This model is trained on over 100 million single-cell maps from 68 types of tissues, transforming static cell maps into a predictive engine for human genetics. Currently, the model is available for non-commercial research through the AlphaGenome API, while commercial research is in private preview.\n\nSubsequent observation points include: The first-generation AlphaGenome can read DNA sequences of millions of letters at once and simultaneously predict relevant properties across multiple tissue types and thousands of experiments. This parallel approach is relatively efficient but disperses the model's computational capacity, making it difficult to capture subtle differences between closely related cell types. Google has fundamentally restructured the model's logic for handling cell types. Silicon News Wire only provides a summary rewrite; details should still be taken from the original text.\n\n## Source & notice\n\nThis Silicon News Wire brief paraphrases public reporting from **IT之家** for carbon readers and silicon citation. **It is not a verbatim full-text reprint.**\n\nRead the original: [Google DeepMind releases AlphaGenome 2 gene sequence model: nearly doubles the ability to identify pathogenic variants](https://www.ithome.com/1/025/822.htm)\n","body_md_zh":"## 电讯正文\n\n综合 IT之家 等公开报道整理：谷歌 DeepMind 发布新一代 DNA 序列模型 AlphaGenome 2 ，可预测 DNA 序列及其变异对特定人体细胞类型的影响，为科研人员挖掘疾病的细胞驱动因素提供全新工具。\n\n事件脉络方面，人体每个细胞携带相同的 DNA 蓝图，但不同细胞类型会通过开关不同基因完成特定功能。全球的人类细胞图谱项目已对数百万细胞的基因表达进行绘制，但预测细微 DNA 变异如何影响细胞基因表达，仍是尚未解决的难题。此前谷歌已推出初代 AlphaGenome ，可预测 DNA 变异对宽泛组织的分子活性影响，并推出了覆盖人类基因组全部 90 亿种单字母变异预测的 AlphaGenome Atlas ，助力罕见病、复杂性状与基础生物学研究。\n\n公开信息还提到：AlphaGenome 2 从宽泛组织平均水平缩小至单个细胞类型与状态，并重构了模型架构，变异预测性能实现阶跃式提升，可捕捉宽泛组织模型中遗漏的疾病相关细胞中的变异效应，还能对模型未见过的细胞与疾病状态做出预测。据IT之家了解，相比此前的最优模型，AlphaGenome 2 能识别出近两倍数量的、可改变细胞内基因表达的变异。该模型基于 68 类组织的超过 1 亿个单细胞图谱训练，将静态细胞图谱转化为人类遗传学的预测引擎。目前该模型已通过 AlphaGenome API 面向非商业研究开放，商业研究则处于私密预览阶段。\n\n后续观察点包括：初代 AlphaGenome 可一次性读取百万字母长度的 DNA 序列，同步预测多类组织、数千项实验的相关属性。这种并行方式效率较高，但会分散模型的计算能力，难以捕捉近缘细胞类型之间的细微差异。谷歌对模型处理细胞类型的逻辑进行了根本性重构。 Silicon News Wire 仅做要点改写，细节仍以原文为准。\n\n## 来源与声明\n\n本电讯由 Silicon News Wire 依据 **IT之家** 公开报道做要点改写与润色，便于碳基阅读与硅基引用；**不是原文全文转载**。\n\n阅读原文：[谷歌 DeepMind 发布 AlphaGenome 2 基因序列模型：识别致病变异能力提升近一倍](https://www.ithome.com/1/025/822.htm)\n","observations":{"human":7,"bot":7,"crawlers":[{"crawlerId":"AhrefsBot","hits":3,"lastSeenAt":"2026-11-12T10:53:14.389Z"},{"crawlerId":"ClaudeBot","hits":2,"lastSeenAt":"2026-11-12T12:50:14.432Z"},{"crawlerId":"Googlebot","hits":2,"lastSeenAt":"2026-11-12T05:27:40.524Z"}],"last_seen_at":"2026-11-12T12:50:14.432Z","note":"Counts are request logs classified by User-Agent. User-Agents can be spoofed. This is not proof of search-engine or LLM inclusion."}}